Clinical Study Results
The table below shows the adverse reactions that happened in at least 2
participants during this study. There were other adverse reactions, but those
happened in fewer participants.
Most common adverse reactions during the study
MEDI0382 Placebo
(out of 18 (out of 7
Adverse reaction participants) participants)
Nausea 66.7% (12) 0.0% (0)
Diarrhoea 16.7% (3) 42.9% (3)
Decreased appetite 27.8% (5) 0.0% (0)
Vomiting 22.2% (4) 14.3% (1)
Changes in ECG results (a possible sign
22.2% (4) 0.0% (0)
of heart damage)
Belching 16.7% (3) 0.0% (0)
Constipation 16.7% (3) 0.0% (0)
Having low energy 16.7% (3) 0.0% (0)
Dizziness 11.1% (2) 0.0% (0)
Skin redness at injection site 11.1% (2) 0.0% (0)
Pain in the stomach area 5.6% (1) 14.3% (1)
How has this study helped patients and researchers?
This study helped researchers learn how MEDI0382 affects body weight, calorie
intake, and calories burned in people who have type 2 diabetes and are overweight
or have obesity.
Researchers look at the results of many studies to decide which treatments work
best and are safest. This summary shows only the main results from this one study.
Other studies may provide new information or different results.
Further clinical studies with MEDI0382 are planned.
11